VHL(In the pipeline)
Von Hippel–Lindau tumor suppressor (VHL) is a protein whose mutated form leads to von Hippel–Lindau disease, which is characterized by an upregulation of angiogenesis related factors. VHL is associated with central nervous system hemangioblastomas, clear cell renal carcinomas, and pheochromocytomas.
|Positive Control||Colon and Thyroid Cancer Tissue|
|Dilution Range||1:100 - 1:200|